DNAnexus
DNAnexus, TMA Precision Health Partner to Advance Rare Disease Research
The collaboration grants rare disease researchers access to DNAnexus' Precision Health Data Cloud and analysis tools alongside TMA's whole-genome sequencing data.
Where'd the Money Go? For Investments in Diagnostics in 2018, Usually to Cancer Test Development
Premium
Excluding IPOs, the funding environment for private venture-backed financing Dx deals in the US and Europe was remarkably similar in 2018 to 2017, according to Silicon Valley Bank.
In Brief This Week: Bruker, Medicover, BC Platforms, Myriad, and More
A brief recap of Diagnostics news the week of Oct 19, 2018: Bruker, Medicover, BC Platforms, Myriad, OneOme, DNAnexus.